Attention Deficit Hyperactivity Disorder (ADHD) is a disruptive disorder that can affect individuals throughout their lives. Keystone Advanced Ketamine Therapy has announced a new treatment option for those struggling with the disorder.
Many people with ADHD cannot manage their symptoms, even with traditional therapy and medications. Ketamine therapy can offer them a new and practical approach to tackling their symptoms.
Ketamine has been approved by the FDA for anesthesia purposes for many years, but research has shown that it can also be effective in treating mood and anxiety disorders.
At Keystone Advanced Ketamine Therapy, clinicians provide a holistic approach to treating ADHD for patients. The therapy sessions are conducted in a tranquil, supportive, and compassionate environment, ensuring the patient feels relaxed.
The clinicians are experts in administering the treatment and understand that every patient’s experience is unique. The team works closely with each patient to create a customized treatment plan that prioritizes their needs.
Individuals in the greater Philadelphia area that are suffering from ADHD should seek treatment at Keystone Advanced Ketamine Therapy, located in Philadelphia, and accepting new patients.
About Keystone Advanced Therapy
Keystone Advanced Ketamine Therapy serves people suffering from depression, chronic pain, PTSD, reflex sympathetic dystrophy (RSD), fibromyalgia, migraines, headaches, and complex regional pain syndrome (CRPS). We provide therapies. The clinic provides cutting-edge, evidence-based therapies to reduce pain and help patients recover from chronic health issues.
This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.
